The 4th Rare Disease Collaboration Summit 2017 is dedicated to the creation of a patient-centric approach to rare disease clinical trial design and a culture of collaboration.
The 4th Rare Disease Collaboration Summit 2017 covers topics such as:
- Strategies for identifying patient-centered clinical endpoints
- The latest case studies on navigating compassionate access requests
- Proven techniques for helping patients retain coverage for orphan drugs as the payer landscape changes
- Success stories of pharma/patient partnerships to accelerate clinical trials
- Updates on the regulatory guidelines determining the clinical and market access development potential for orphan drugs
The 4th Rare Disease Collaboration Summit 2017 brings together senior attendees involved or interested in:
- Members of the rare disease community
- Representatives from pharmaceutical, biotechnology and medical device companies
- Reimbursement/Insurance Industry Law Firms
- Regulatory Law Firms